TickerGuard
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Core Scientific, Inc. (CORZ)

Technology Software - Infrastructure
20.70 $
-5.0% vs. previous close
Closing price · As of: 31. Jul 2026
🔔 Watch stock

Stock Watch

Stock Watch will tell you what changes at Core Scientific, Inc..

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Appears in These Scanners

This stock currently matches 33 of our scanner strategies — each hit links to the scanner.

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners

Trading Day

Previous Close
21.80$
Open
23.00$
Day High
23.00$
Day Low
20.70$
Volume
11,958,512shares

Key levels of the most recently completed trading day — not a live quote.

52-Week Range

52-Week Low 52-Week High
12.70 $ 29.20 $
08/01/2025 06/18/2026

Current price 20.70 $ — 49% of the range above the low.

Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.

Basics

Market Cap
6.6$B
Shares Outstanding
321Mio.
Float
80.6%
Beta
5.5

Performance

Perf. 1M
-6.60%
Perf. 3M
72.10%
Perf. 6M
66.60%
YTD Performance (%)
100.30%
52-Week-High Distance
-10.5%
Perf. 1Y
53.03%
Perf. 5Y
707.85%
Perf. Since Inception
502.33%

Technical Indicators

MA 38 Days
24.50$
MA 50 Days
25.00$
MA 200 Days
19.70$
RSI (14)
43.3
Volatility 30 Days
101.5%
Volatility 250 Days
68.9%

Calculated from the price history · as of 08/03/2026

Valuation

P/E
Forward P/E
166.7
PEG
P/B
0.0
P/S
14.9
EV/EBITDA
454.9
Price/FCF

Profitability

Gross Margin
32.1%
EBIT Margin
-18.8%
Net Margin
0.0%
Return on Equity
0.0%
Return on Assets
-2.4%

Balance Sheet & Safety

very low
Equity Ratio
-42.5%
Debt/Equity
-1.6
warning zone
Altman Z″
-5.06
Piotroski
4 out of 9

Growth

Sales Growth Last Quarter
44.90%
EPS Growth Last Quarter
61.20%
Sales Growth (Year)
-37.53%
Forward Sales Growth
71.23%
Forward EPS Growth
128.50%

Dividend

This stock currently pays no dividend.

Quality & Screener

Stage
2
Top 10%
RS Rating
93
EPS Rating
80
Piotroski
4 out of 9
Fundamental Rating
D (44 out of 100)
warning zone
Altman Z″
-5.06

AI Rating

Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built

Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.

Analysts & Price Target

Current Price 20.70 $
Price Target (average) 37.13 $

The price target sits 79.4% above the current price.

Consensus
Strong Sell
Analyst Ratings
16
Distribution of Recommendations
Strong Buy 12
Buy 3
Hold 1
Sell 0
Strong Sell 0

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Estimates by Fiscal Year

Estimates by Fiscal Year
Fiscal Year EPS Estimate ($) EPS Range ($) Revenue Estimate ($M) Expected Growth Analysts
12/31/2026 -3.88 -4.66 – -3.09 671 -535.2% 2
12/31/2027 0.19 0.11 – 0.26 1,162 104.8% 2

Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.

Next Reporting Date

14. Aug 2026

Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.

Revenue & Profit

Cash Flow

Balance Sheet

Margins

Per Share

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)
2024: Q4 · 94.9 $M Q4 2025: Q1 · 79.5 $M Q1 2025: Q2 · 78.6 $M Q2 2025: Q3 · 81.1 $M Q3 2025: Q4 · 79.8 $M Q4 2026: Q1 · 115.2 $M Q1 2026: Q2 · 164.2 $M Q2

Source: fundamental data

Compare with other stocks →

Quarterly Figures

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q4 -0.69 95 -33.10 -279.70 14 -15
2025: Q1 1.24 59.00 80 -55.60 724.60 -41 -129
2025: Q2 -2.95 79 -44.30 -1,191.40 34 -87
2025: Q3 -0.46 81 -14.90 -180.80 132 -123
2025: Q4 0.67 80 -16.00 268.50 153 -122
2026: Q1 -1.08 -187.10 115 44.90 -301.30 250 -139
2026: Q2 -3.32 -12.50 164 108.90 -703.60 -19 -584
What Do These Terms Mean?
EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

Annual Figures

Annual Figures
Fiscal Year Revenue ($M) EBIT ($M) Net Income ($M) EPS ($) Operating Cash Flow ($M) Equity ($M) Total Assets ($M)
2019 60 -12 -12 -0.03 -1 136 162
2020 60 -6 -12 -0.03 -24 134 226
2021 544 167 47 0.20 -57 1,341 2,439
2022 640 -245 -2,146 -5.72 205 -409 808
2023 502 9 -246 -0.65 65 -597 712
2024 511 -19 -1,315 -5.14 43 -820 1,599
2025 319 -225 -289 -0.91 278 -963 2,348

Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.

About the Company

Core Scientific, Inc. bietet Infrastruktur für High-Density-Colocation-Dienste und Mining digitaler Vermögenswerte in den USA an.

Employees325
HeadquartersDover, DE
Address838 Walker Road, 19904 Dover, United States
Phone512 402 5233
Websitecorescientific.com
IPO Date24. Jan 2024
ISINUS21874A1060

Management

Management
Name Title Birth Year
Adam Sullivan CEO, President & Director 1992
James P. Nygaard Jr. Executive VP & CFO 1975
Todd M. Duchene J.D. Executive VP, Chief Legal and Administrative Officer & Secretary 1964
Matt Brown Chief Operating Officer
Jorge Ray Chief Accounting Officer 1983
Larry Kom Ph.D. Chief Technology Officer
Sean T. Kimble Chief Human Resources Officer 1965
Jeff Taylor Chief Information Security Officer
Russell Cann Chief Development Officer
Lynn Burgener Senior VP of Tax & Trade

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
27. Jul 2026 Duchene Todd M See remarks Sell 100 22.49 2,249
27. Jul 2026 Duchene Todd M See remarks Sell 1,600 21.89 35,028
27. Jul 2026 Duchene Todd M See remarks Sell 8,300 20.75 172,199
20. Jul 2026 Duchene Todd M See remarks Sell 10,000 22.30 222,995
16. Jul 2026 Sullivan Adam Taylor Chief Executive Officer Other 15,584 22.72 354,068
16. Jul 2026 Duchene Todd M See remarks Other 4,325 22.72 98,264
13. Jul 2026 Duchene Todd M See remarks Sell 300 23.01 6,903
13. Jul 2026 Duchene Todd M See remarks Sell 9,700 22.43 217,572
6. Jul 2026 Duchene Todd M See remarks Sell 10,000 22.63 226,254
20. Apr 2026 Todd M Duchene Insider Sell 10,000 19.80 198,000

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

View all insider transactions →

Chart

Interactive price chart (TradingView).

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?